Oxelumab

From WikiMD's WELLNESSPEDIA

Oxelumab
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number 1186098-83-8
PubChem
DrugBank
ChemSpider none
KEGG


Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]

Oxelumab was developed by Genentech and co-developed by Roche.

References[edit]

  1. Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab(link). {{{website}}}. American Medical Association.